Personalized vaccine for advanced colon or pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests a personalized vaccine (ODI-2001) that is made from your own tumor. It is given during a break from chemotherapy to see if it is safe and can help keep the cancer from growing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have advanced colon or pancreatic cancer that cannot be removed with surgery.
- You are about to start your first chemotherapy treatment.
- You have at least one tumor that can be measured on a CT scan.
- Your cancer must shrink after the first round of chemotherapy (at least 30% for colon, 20% for pancreatic).
- You are generally in good health (able to do daily activities) and have adequate organ function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a custom-made T-cell treatment designed to target unique markers on your tumor. It's for people with advanced colorectal cancer who have run out of standard options or can't take them, and it aims to shrink tumors and improve survival.
This study tests a personalized vaccine made from your tumor's unique markers. It aims to help your immune system attack pancreatic cancer that has spread or returned.
This early-phase trial tests a personalized cancer vaccine made from your tumor, along with pembrolizumab, to help the immune system attack advanced pancreatic cancer. It may be an option if your cancer has specific immune “targets” and if you meet several health, lab, and infection requirements.
This trial tests a personalized vaccine made from your own tumor's genetic information. The vaccine is given after surgery to try to train your immune system to fight any remaining cancer cells and reduce the chance of the cancer coming back.
This trial tests a personalized vaccine made from your tumor's unique features, combined with a standard second-line treatment, for colorectal cancer that has worsened after the first treatment. The goal is to see if this combination can help control the cancer better than standard therapy alone.
This trial tests a personalized vaccine made from your cancer's unique markers. The goal is to train your immune system to fight the cancer, potentially slowing it down when other options have run out.
Hear when a new Metastatic Colorectal Cancer (CRC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.